1. Home
  2. SLNO vs HAYW Comparison

SLNO vs HAYW Comparison

Compare SLNO & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • HAYW
  • Stock Information
  • Founded
  • SLNO 1999
  • HAYW 1925
  • Country
  • SLNO United States
  • HAYW United States
  • Employees
  • SLNO N/A
  • HAYW N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HAYW Electronic Components
  • Sector
  • SLNO Health Care
  • HAYW Technology
  • Exchange
  • SLNO Nasdaq
  • HAYW Nasdaq
  • Market Cap
  • SLNO 3.7B
  • HAYW 3.3B
  • IPO Year
  • SLNO 2014
  • HAYW 2021
  • Fundamental
  • Price
  • SLNO $46.98
  • HAYW $15.84
  • Analyst Decision
  • SLNO Strong Buy
  • HAYW Buy
  • Analyst Count
  • SLNO 9
  • HAYW 4
  • Target Price
  • SLNO $114.89
  • HAYW $18.00
  • AVG Volume (30 Days)
  • SLNO 2.2M
  • HAYW 2.3M
  • Earning Date
  • SLNO 11-04-2025
  • HAYW 10-29-2025
  • Dividend Yield
  • SLNO N/A
  • HAYW N/A
  • EPS Growth
  • SLNO N/A
  • HAYW 44.13
  • EPS
  • SLNO N/A
  • HAYW 0.62
  • Revenue
  • SLNO $98,675,000.00
  • HAYW $1,099,855,000.00
  • Revenue This Year
  • SLNO N/A
  • HAYW $6.69
  • Revenue Next Year
  • SLNO $181.30
  • HAYW $5.53
  • P/E Ratio
  • SLNO N/A
  • HAYW $25.65
  • Revenue Growth
  • SLNO N/A
  • HAYW 9.66
  • 52 Week Low
  • SLNO $41.50
  • HAYW $11.10
  • 52 Week High
  • SLNO $90.32
  • HAYW $17.73
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 31.94
  • HAYW 50.26
  • Support Level
  • SLNO $66.12
  • HAYW $15.89
  • Resistance Level
  • SLNO $69.99
  • HAYW $16.37
  • Average True Range (ATR)
  • SLNO 3.71
  • HAYW 0.45
  • MACD
  • SLNO -2.47
  • HAYW 0.00
  • Stochastic Oscillator
  • SLNO 18.57
  • HAYW 33.04

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About HAYW Hayward Holdings Inc.

Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2024.

Share on Social Networks: